000 01843 a2200517 4500
005 20250517061357.0
264 0 _c20160706
008 201607s 0 0 eng d
022 _a1474-4457
024 7 _a10.1016/S1473-3099(15)00345-X
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOlveda, Remigio M
245 0 0 _aEfficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial.
_h[electronic resource]
260 _bThe Lancet. Infectious diseases
_cFeb 2016
300 _a199-208 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650 0 4 _aAdult
650 0 4 _aAnthelmintics
_xadministration & dosage
650 0 4 _aBirth Weight
_xdrug effects
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aFetus
_xdrug effects
650 0 4 _aGestational Age
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aPhilippines
650 0 4 _aPraziquantel
_xadministration & dosage
650 0 4 _aPregnancy
650 0 4 _aSchistosomiasis
_xdrug therapy
650 0 4 _aYoung Adult
700 1 _aAcosta, Luz P
700 1 _aTallo, Veronica
700 1 _aBaltazar, Palmera I
700 1 _aLesiguez, Jenny Lind S
700 1 _aEstanislao, Georgette G
700 1 _aAyaso, Edna B
700 1 _aMonterde, Donna Bella S
700 1 _aIda, Antonio
700 1 _aWatson, Nora
700 1 _aMcDonald, Emily A
700 1 _aWu, Hannah W
700 1 _aKurtis, Jonathan D
700 1 _aFriedman, Jennifer F
773 0 _tThe Lancet. Infectious diseases
_gvol. 16
_gno. 2
_gp. 199-208
856 4 0 _uhttps://doi.org/10.1016/S1473-3099(15)00345-X
_zAvailable from publisher's website
999 _c25397445
_d25397445